Search results
Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 hours agoRegulatory and Legal Risks: ALNY operates in a heavily regulatedindustry, where changes in...
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating...
Simply Wall St. via Yahoo Finance· 5 days agoThe consensus price target held steady at US$395, with the latest estimates not... Wall St, we have...
Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances
GuruFocus.com via Yahoo Finance· 13 hours agoThe company reported a notable 32% increase in total revenue year-over-year, reaching $17...better than the anticipated loss of $12.91 million. Company Overview< ...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoEli Lilly and Co continues to invest heavily in research and development, which is crucial for...
Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
GuruFocus.com via Yahoo Finance· 2 days agoAdditionally, net income stood at $9.0 million, a stark contrast to the $43.0 million loss estimated by analysts and the $186.2 million loss reported in the previous year.
Cencora Inc (COR) Q2 Earnings: Adjusted EPS Exceeds Expectations
Guru Focus· 2 days agoOn May 1, 2024, Cencora Inc (COR, Financial), a dominant force in the pharmaceutical wholesale industry, disclosed its financial results for the second ...
Sensient Technologies Corp (SXT) Q1 Earnings: Mixed Results Amidst Market Challenges
GuruFocus.com via Yahoo Finance· 7 days agoThis guidance reflects an optimistic outlook compared to the 2023 reported GAAP diluted earnings per...
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig
Guru Focus· 1 day agoThis...impressive growth is mirrored in the company's net income, which rose from $240.9 million to $306.6 million year-over-year. This financial overview sets the stage for ...
APEGA concludes annual general meeting, Tracey Stock installed as 105th president
Digital Journal· 15 hours agoShareholders...
7 Analysts Assess Alkermes: What You Need To Know - Alkermes (NASDAQ:ALKS)
Benzinga· 17 hours agoDebt Management: Alkermes's debt-to-equity ratio is below the industry average. With a ratio of 0.31 , the company relies less on debt financing, maintaining a healthier balance ...